30 September 2024
Kia ora, In this issue Insights from our Executive Director The more I work in this role the more excited I am about the convergence of once-siloed technologies across multidisciplinary … Continue reading "Level 1 great news for cannabis summit – waiting list now open"
Read More
03 September 2024
In this issue Insights from our Executive Director During the last month there has been plenty of discussion in the media regarding gene technologies – should our companies and researchers … Continue reading "Level 1 great news for cannabis summit – waiting list now open"
Read More
02 September 2024
We can’t wait to reconnect at Aotearoa New Zealand’s 2025 Life Science Summit – Uniting biology and technology to unleash potential. 18-19 March, 2025 at Tākina Wellington Convention and Exhibition Centre. Click here … Continue reading "Level 1 great news for cannabis summit – waiting list now open"
Read More
21 June 2024
It has been another busy month for biotech. More than 35 Kiwis travelled to the BIO International Convention in San Diego.
Read More
06 March 2024
In this issue Insights from our Executive Director This year feels like it’s going to be a fast game, but a good game for the biotech sector! I am incredibly … Continue reading "Level 1 great news for cannabis summit – waiting list now open"
Read More
“Alert Level 1 is exciting news for large and important events like ours,” says Dr Zahra Champion, Executive Director of BioTechNZ and MedCan Summit 2020 organiser in response to the Prime Minister’s confirmation that Auckland will join the rest of the country on Level 1 at 12.59pm on Wednesd
October 5, 2020
Minister Jacinda Ardern and Director-General of Health Dr Ashley Bloomfield provided a COVID-19 update on COVID-19 daily and both use terminology like genomic testing, genomic sequencing, DNA, vaccines, viruses, cells, antibodies, epidemiology, microbiology and handwashing, masks and NZ COVID Trace
September 18, 2020
It’s only two months until New Zealand’s first medicinal cannabis summit, MedCan 2020, with organisers saying the economic potential of New Zealand’s most exciting sunrise industry is more important than ever before. MedCan Summit 2020 will take place on Monday 9 and Tuesday 10 N
September 7, 2020
Many friends and colleagues attended the Aroa Biosurgery (ASX:ARX) listing on the ASX, ceremony and celebration at the end of July. Aroa is a soft-tissue regeneration company, founded in 2008.“You all know biotechnology is an important part of New Zealand's future” Peter Hodgson, Rese
August 18, 2020
For those members who were unable to join us for the Annual Meeting on 21st July 2020, you can view the meeting presentation here.
July 22, 2020
The Precautionary Principle, there are many definitions, but the most common expression today claims that a practice, substance or technology must be banned or prohibited if it cannot be proven (with certainty) to be safe. Rather than trying to reduce exposure to risks or solve problems with innova
July 3, 2020
Congratulations to our Neonatal expert Professor Jane Harding as she is now one of the Dame Companions of the New Zealand Order of Merit (NZOM). Congratulations also to medical researcher Professor Robert Elliott who has been appointed Knight Companions of the NZOM. Well deserved recog
June 3, 2020
Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis. Pictor has received a grant of $500,000 from the $25 million MBIE COVID-19 Innovation Acceleration Fund,
May 18, 2020
New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
May 8, 2020